Walk-in || Mulitple Openings

Brooks Steriscience's state-of-the-art manufacturing facility is compliant with cGMP standards, adhering to both national and international regulations. These facilities, dedicated to the production of Carbapenem Injections and APIs, have received approvals from major international regulatory agencies, including the US FDA, MHRA (UK), Federal Ministry of Health-Germany, SAPHRA (South Africa), Department of Health (Canada), INVIMA (Colombia), ANVISA (Brazil), WHO, and various other national health ministries.

Brooks Steriscience Limited is a state-of-the-art manufacturing facility specializing in Carbapenem formulations and APIs. Headquartered in India, it maintains compliance with cGMP standards and holds approvals from esteemed regulatory agencies such as the US FDA, EU-GMP, MHRA (UK), WHO, and more. With over 75 marketing authorizations globally, the company is recognized for its innovative and integrated product portfolio of Carbapenem injectables. Brooks Steriscience is one of India's largest manufacturers of Carbapenem injections, including formulations such as Meropenem, Imipenem + Cilastatin, Doripenem, and Ertapenem.

With over 75+ marketing authorizations across the globe, the company's product portfolio includes innovative and vertically integrated formulations.
Brooks Steriscience Ltd, one of the largest manufacturing units for Carbapenems Injection in India.